Linkwell concerned with misunderstanding of prevention and control measures of H1N1

Sep 2 2009

Linkwell Corporation (OTC Bulletin Board: LWLL), a leading developer, manufacturer and distributor of healthcare-related disinfectants in China, put forward its worries about the trend of the misunderstanding concerning dealing with the spread of H1N1.

"Antisepsis is one of the most effective measures to prevent and control infectious diseases, and it will work best when used with the H1N1 vaccine," said Xuelian Bian, the Chairman and CEO of Linkwell Corporation, concerning the increasingly severe worldwide outbreak of H1N1 influenza. "Nearly all countries are making H1N1 vaccine production a top priority, which will bring some certain potential risks. With several years of experience in epidemiological research and infectious diseases in the Second Military Medical University, I am well aware of the current vaccine developments and production speed cannot keep up with the rate of virus mutation. In fact, the most economical and effective way to prevent the virus is to disinfect the breeding ground for pathogens, cutting off their routes of transmission by strengthening the personal hygiene, disinfection and isolation protection of susceptible people. The Chinese Ministry of Health has attached increasingly great importance to disinfection in medical institutions in recent years. At present, it is the Chinese masses that need to be educated about disinfection, so that more people know how to use antisepsis and health care products correctly."

Mr. Bian also commented, "To confront H1N1 influenza, Linkwell's 90%-held subsidiary, Likang Company, as a professional disinfectant supplier, contributes actively and responsibly. In the first half of this year, bottled disinfectants sent to most of hospitals around the country increased by tens of thousands, owing to the H1N1 disease. Due to last year's Wenchuan Earthquake in China, Likang was ordered by China's Ministry of Health to provide to the disaster areas a large amount of disinfectant, of which more than 400 tons were transported by air due to urgent need.

"We are carrying out R&D on new types of disinfectant to combat the influenza virus," Chairman Xuelian Bian emphasized, "Over the past few years, Likang has focused on the medical disinfection market in China, rejecting offers of cooperation from institutional investors who have wanted to invest in the civilian public health market many times. Nevertheless, the situation of the outbreak of infectious diseases throughout the world is becoming more urgent. China's 1.3 billion people make up a more than 30 billion market shares in the huge market of infection control. To Likang company, which holds a large number of civilian disinfection product technology patents, the decision to penetrate the civil disinfection market and other related markets will not only provide the most professional products and services to the whole community, but also lead to rapid growth and expansion for the company."

Source: http://www.linkwell.us